ASH ISTH NHF WFH Clinical Practice Guidelines on von Willebrand Disease
The American Society of Hematology (ASH), in collaboration with the International Society on Thrombosis and Haemostasis (ISTH), National Hemophilia Foundation (NHF), and World Federation of Hemophilia (WFH), has developed clinical practice guidelines on the diagnosis and management of VWD.
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
- ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
Learn more about the development process behind the ASH ISTH NHF WFH VWD guidelines.
View the international survey which highlighted areas of importance to a diverse representation of stakeholders in the diagnosis and management of VWD, providing a framework for future guideline development and implementation.
Guideline Implementation Tools and Resources
ASH guidelines are reviewed annually by expert work groups convened by ASH. Resources derived from guidelines that require updating are removed from the ASH website.
These one-page snapshots provide a high-level summary of the ASH ISTH NHF WFH VWD Guidelines.
VWD Guidelines: What You Should Know
ASH Clinical Practice Guidelines App
The ASH Clinical Practice Guidelines App provides easy access to every recommendation from all guidelines published by ASH, including rationale for each recommendation, benefits and harms associated with each recommended course of action, and links to the complete evidence-to-decision tables used to develop the recommendations. This app is also available via web interface.
Download for iOS Download for Android
Pocket Guides
ASH has developed a series of brief, evidence-based pocket guides to help physicians provide quality care to patients. The pocket guides are available via the ASH Pocket Guides App for IOS and Android devices. This app is also available via web interface.
Download for iOS Download for Android
Webinar
This webinar highlights recommendations along with underlying evidence and rationale for the recommendations for the ASH ISTH NHF WFH guidelines on the diagnosis and management of von Willebrand disease.
Teaching Slides
Help your colleagues diagnose, manage, and treat VWD with the following teaching slides designed for easy dissemination:
- Diagnosis and Management of VWD
Powerpoint | PDF
Additional resources
The following resources, developed externally and based on the ASH ISTH NHF WFH VWD guidelines, are provided for reference. Please note that the American Society of Hematology does not endorse, nor is it responsible for, the content of these resources
- ISTH resources
- NHF resources
- WFH resources
- The Haemophilia Journal has published the commentary, Diagnosis and management of von Willebrand disease: A community‐wide effort to deliver evidence‐based clinical practice guidelines by Barb Konkle on behalf of the World Federation of Hemophilia and Steve Pipe on behalf of the National Hemophilia Foundation
- The Center for Disease Control's Division of Blood Disorders (DBD) is proud to offer its Public Health Webinar Series on Blood Disorders entitled Joint Guidelines on the Diagnosis and Management of von Willebrand Disease. The purpose of this series is to provide evidence-based information on new research, interventions, emerging issues of interest in blood disorders, as well as innovative approaches in collaborations and partnerships. Watch the webinar here.
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission